Cargando…
A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies
Rationale: The blood-brain barrier (BBB) is a major impediment to therapeutic intracranial drug delivery for the treatment of neurodegenerative diseases, including Alzheimer's disease (AD). Focused ultrasound applied together with microbubbles (FUS(+MB)) is a novel technique to transiently open...
Autores principales: | Wasielewska, Joanna M., Chaves, Juliana C. S., Johnston, Rebecca L., Milton, Laura A., Hernández, Damián, Chen, Liyu, Song, Jae, Lee, Wendy, Leinenga, Gerhard, Nisbet, Rebecca M., Pébay, Alice, Götz, Jürgen, White, Anthony R., Oikari, Lotta E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576609/ https://www.ncbi.nlm.nih.gov/pubmed/36276649 http://dx.doi.org/10.7150/thno.72685 |
Ejemplares similares
-
A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease
por: Leinenga, Gerhard, et al.
Publicado: (2021) -
Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody
por: Janowicz, Phillip W., et al.
Publicado: (2019) -
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model
por: Nisbet, Rebecca M., et al.
Publicado: (2017) -
Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions
por: Pandit, Rucha, et al.
Publicado: (2019) -
What Renders TAU Toxic
por: Götz, Jürgen, et al.
Publicado: (2013)